Manifestation of anterior necrotising scleritis and reactive infectious mucocutaneous eruption after COVID-19 2022: A case report

ABSTRACT

Purpose: To report a case of reactive infectious mucosal eruption and anterior scleritis in a vaccinated patient following recent recovery from COVID-19. Reactive infectious mucosal eruption (RIME) is a newly recognised complication of SARS COVID-19. Scleritis has also been reported in COVID-19 infections;however, these cases were from early in pandemic prior to vaccine development and were not reported to occur concurrently with RIME. Method(s) This case report illustrates a 25-year old male fully vaccinated against COVID-19 (ComirnatyTM) who presented 2 weeks after recovering from COVID-19 infection with RIME involving the oral mucosal and larynx, and concurrent bilateral anterior necrotising scleritis. Result(s) Consultation was sought from ophthalmology, otolaryngology and dermatology and dental regarding diagnoses and management. The patient's condition rapidly improved following treatment with IV methyprednisolone and oral prednisone taper. Conclusion(s) In cases of diagnostic uncertainty, multidisciplinary collaboration is critical to achieve a timely diagnosis and prevent serious complications.